Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McGill University

$28,000.00

Characterization of pathogen transport through biofluid barriers

EF 2024-25

Résumé
Mucosal barriers are key components of the innate immune system that influence disease transmission by interacting with and sequestering pathogens within-hosts and by influencing pathogen survival at the point of transmission. To date, our understanding of the biophysical mechanisms governing interactions between pathogens and mucin glycoproteins, the primary structural components of mucus, remains incomplete. This hinders our ability to understand and model pathogen dynamics in-host, particularly during the initial stages of infection where causative pathogenic agents must traverse mucosal barriers and overcome host innate immune responses. It also limits our ability to rationally design biomaterials that mimic mucins in their ability to sequester and neutralize pathogens. Addressing these limitations aligns with the long-term research objectives of my team, namely to develop novel, biophysically informed mathematical models for pathogen spread and to develop mucin-mimetic biomaterials capable of sequestering pathogens. The foundational basic science necessary to achieve these objectives involves characterizing the transport, mobility, and infectivity of pathogens in mucosal barriers. Therefore, this Discovery program will focus on understanding the physical processes that govern pathogen/mucin interactions and the transport of pathogens through mucin gels using virions as a model pathogen system. The specific research aims are: Aim 1: We will characterize the effect of mucin barriers on the mobility and transport of viruses and pseudovirions using both experimental and modeling techniques. The mucus layer lining the respiratory tract presents a first obstacle to respiratory viruses for establishing infection, and elucidating possible virus-mucin interactions will be crucial for understanding and modeling this stage of the infection process. Aim 2: We will directly measure the effect of mucins on viral infection. To do so, we will perform cell transduction experiments in the presence and absence of mucin gels and native mucus, using the virions described in Aim 1. These results will allow us to directly identify key structural components of viruses and mucins that permit or restrict viral transport, binding to cellular receptors, and entry into cells. This research will improve our understanding of interactions between mucins (and mucosal barriers) and pathogens, and the effect of these interactions on the early stages of host infection. This will provide the basis for the development of novel biophysically accurate models for pathogen spread. Additionally, an improved understanding of how pathogens interact physiochemically with biological molecules will be critical in guiding the development of biomaterials designed to sequester pathogens. Importantly, this research progress will proceed concurrently with the interdisciplinary training of HQP in areas ranging from biological fluid characterization to mathematical model development.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2022-03617
Name nom
Wagner, Caroline
Department département
Bioengineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Characterization of pathogen transport through biofluid barriers
Keywords
mucin; biogels; rheology; virions
Application summary
Mucosal barriers are key components of the innate immune system that influence disease transmission by interacting with and sequestering pathogens within-hosts and by influencing pathogen survival at the point of transmission. To date, our understanding of the biophysical mechanisms governing interactions between pathogens and mucin glycoproteins, the primary structural components of mucus, remains incomplete. This hinders our ability to understand and model pathogen dynamics in-host, particularly during the initial stages of infection where causative pathogenic agents must traverse mucosal barriers and overcome host innate immune responses. It also limits our ability to rationally design biomaterials that mimic mucins in their ability to sequester and neutralize pathogens. Addressing these limitations aligns with the long-term research objectives of my team, namely to develop novel, biophysically informed mathematical models for pathogen spread and to develop mucin-mimetic biomaterials capable of sequestering pathogens. The foundational basic science necessary to achieve these objectives involves characterizing the transport, mobility, and infectivity of pathogens in mucosal barriers. Therefore, this Discovery program will focus on understanding the physical processes that govern pathogen/mucin interactions and the transport of pathogens through mucin gels using virions as a model pathogen system. The specific research aims are: Aim 1: We will characterize the effect of mucin barriers on the mobility and transport of viruses and pseudovirions using both experimental and modeling techniques. The mucus layer lining the respiratory tract presents a first obstacle to respiratory viruses for establishing infection, and elucidating possible virus-mucin interactions will be crucial for understanding and modeling this stage of the infection process. Aim 2: We will directly measure the effect of mucins on viral infection. To do so, we will perform cell transduction experiments in the presence and absence of mucin gels and native mucus, using the virions described in Aim 1. These results will allow us to directly identify key structural components of viruses and mucins that permit or restrict viral transport, binding to cellular receptors, and entry into cells. This research will improve our understanding of interactions between mucins (and mucosal barriers) and pathogens, and the effect of these interactions on the early stages of host infection. This will provide the basis for the development of novel biophysically accurate models for pathogen spread. Additionally, an improved understanding of how pathogens interact physiochemically with biological molecules will be critical in guiding the development of biomaterials designed to sequester pathogens. Importantly, this research progress will proceed concurrently with the interdisciplinary training of HQP in areas ranging from biological fluid characterization to mathematical model development.